re: 5. audio: interview with md. 5 "Stainless" advised us of the EPT's MD attending this interview by the "wallstreet reporter":
http://www.wallstreetreporter.com/profiles/EpiTan.html
(Realplayer required).
Summary:
"EpiTan Limited (ASX ticker:"EPT") is an emerging biotechnology company with a pre-eminent position in the prevention of DNA & skin damage from ultra-violet (UV) radiation exposure through the stimulation of melanogenesis.
Based in Melbourne, Australia, EpiTan holds a unique technology platform centred on its leading drug candidate Melanotan®.
The company has the exclusive worldwide rights to develop Melanotan which, like sunlight, stimulates the production of melanin (melanogenesis -a unique biochemical process) in the skin resulting in a tan. Simply, it allows a tan to develop without exposure to harmful levels of UV light".
5. data and comments. 5, page-3
-
- There are more pages in this discussion • 189 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.28 |
Change
-0.115(0.75%) |
Mkt cap ! $773.1M | |||
| Open | High | Low | Value | Volume |
| $15.39 | $16.02 | $15.22 | $1.966M | 125.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 49 | $15.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.29 | 49 | 2 |
View Market Depth
| Last trade - 15.35pm 24/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |